---
figid: PMC5978257__oncotarget-09-22680-g007
figlink: /pmc/articles/PMC5978257/figure/F7/
number: F7
caption: In endothelial cells (EC), TRC105 blocks CD105 favouring the TGF-ß receptor/ALK5
  complex signaling. This complex phosphorylates and activates Smad 2/3 which can
  translocate in the nucleus leading to endothelial cell apoptosis. Sunitinib inhibits
  the signaling pathway of VEGF receptor 2 (KDR), resulting in a reduced Akt activity.
  In the presence of both drugs, Akt is synergistically inhibited by Sunitinib and
  by Smad 2/3 resulting in a reduced phosphorylation of the transcription factor Creb,
  involved in cell activation. Other tyrosine kinase inhibitors (Axitinib, Sorafenib
  and Cabozantinib), show a predominant modulation of the Erk pathway and do not affect
  Creb phosphorylation. No synergistic effect of TRC105 is present in combination
  with Axitinib, Sorafenib and Cabozantinib on VEGF receptor signaling pathways.
pmcid: PMC5978257
papertitle: Effect of the monoclonal antibody TRC105 in combination with Sunitinib
  on renal tumor derived endothelial cells.
reftext: Alessia Brossa, et al. Oncotarget. 2018 Apr 27;9(32):22680-22692.
pmc_ranked_result_index: '95646'
pathway_score: 0.9512579
filename: oncotarget-09-22680-g007.jpg
figtitle: Effect of the monoclonal antibody TRC105 in combination with Sunitinib on
  renal tumor derived endothelial cells
year: '2018'
organisms:
- Homo sapiens
ndex: fc82a137-def3-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5978257__oncotarget-09-22680-g007.html
  '@type': Dataset
  description: In endothelial cells (EC), TRC105 blocks CD105 favouring the TGF-ß
    receptor/ALK5 complex signaling. This complex phosphorylates and activates Smad
    2/3 which can translocate in the nucleus leading to endothelial cell apoptosis.
    Sunitinib inhibits the signaling pathway of VEGF receptor 2 (KDR), resulting in
    a reduced Akt activity. In the presence of both drugs, Akt is synergistically
    inhibited by Sunitinib and by Smad 2/3 resulting in a reduced phosphorylation
    of the transcription factor Creb, involved in cell activation. Other tyrosine
    kinase inhibitors (Axitinib, Sorafenib and Cabozantinib), show a predominant modulation
    of the Erk pathway and do not affect Creb phosphorylation. No synergistic effect
    of TRC105 is present in combination with Axitinib, Sorafenib and Cabozantinib
    on VEGF receptor signaling pathways.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SMAD1
  - SMAD2
  - KDR
  - SMAD3
  - SMAD4
  - MAPK3
  - ATF2
  - CREB3L4
  - ATF1
  - CREB1
  - TGFB3
  - TGFBR3
  - AKT2
  - SMAD9
  - CREB3L2
  - SMAD5
  - SMAD6
  - ENG
  - VEGFC
  - MAPK1
  - AKT3
  - AKT1
  - CREB5
  - TGFBR1
  - TGFBR2
  - CREB3L3
  - VEGFD
  - CREM
  - CREB3
  - TGFB2
  - VEGFB
  - PGF
  - TGFB1
  - SMAD7
  - VEGFA
  - CREB3L1
  - Axitinib
  - Sorafenib
  - Sunitinib
  - Cabozantinib
genes:
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD1
  entrez: '4086'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: KDR
  symbol: KDR
  source: hgnc_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: TGFB-R
  symbol: TGFBR
  source: bioentities_symbol
  hgnc_symbol: TGFBR3
  entrez: '7049'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD9
  entrez: '4093'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD5
  entrez: '4090'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD6
  entrez: '4091'
- word: CD105
  symbol: CD105
  source: hgnc_alias_symbol
  hgnc_symbol: ENG
  entrez: '2022'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: SMAD1/5
  symbol: SMAD5
  source: hgnc_symbol
  hgnc_symbol: SMAD5
  entrez: '4090'
- word: SMAD1/5
  symbol: SMAD1
  source: hgnc_symbol
  hgnc_symbol: SMAD1
  entrez: '4086'
- word: SMAD2/3P
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: TGFB-R
  symbol: TGFBR
  source: bioentities_symbol
  hgnc_symbol: TGFBR1
  entrez: '7046'
- word: TGFB-R
  symbol: TGFBR
  source: bioentities_symbol
  hgnc_symbol: TGFBR2
  entrez: '7048'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD7
  entrez: '4092'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
chemicals:
- word: Axitinib
  source: MESH
  identifier: C503983
- word: Sorafenib
  source: MESH
  identifier: C471405
- word: Sunitinib
  source: MESH
  identifier: C473478
- word: Cabozantinib
  source: MESH
  identifier: C558660
diseases: []
figid_alias: PMC5978257__F7
redirect_from: /figures/PMC5978257__F7
figtype: Figure
---
